Skip to main content
. 2017 Jun 30;8:773. doi: 10.3389/fimmu.2017.00773

Figure 3.

Figure 3

Treatment regimen. The myeloablative conditioning chemotherapy before transplantation consisted of thiotepa, fludarabine, treosulfane, and antithymocyte globulin. Cyclosporine A and methotrexate were given as immunosuppressive prophylaxis for graft-versus-host disease (GvHD) after transplantation.